Opportunistic Risk Screening for Type 2 Diabetes: Exploring of Application of Diabetes Risk Assessment Tool in Community Pharmacy in Australia and Thailand

Value in Health Regional Issues

Volumn 9, Issue , 2016, Pages 1-7

  Thoopputra, Thitaporn ^a   Pongmesa, Tipaporn ^b   Newby, David Andrew ^c   Schneider, Jennifer ^a   Li, Shu Chuen ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b SILPAKORN UNIVERSITY   (Thailand)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Community pharmacy; Health promotion; Pharmacy practice; Prevention; Risk assessment; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; COMMUNITY; FEMALE; GOVERNMENT; HEALTH CARE; HEALTH CARE MANPOWER; HEALTH PROMOTION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING; SEMI STRUCTURED INTERVIEW; THAILAND; NEW SOUTH WALES; PROFESSIONAL STANDARD;

AUSTRALIA; COMMUNITY PHARMACY SERVICES; DIABETES MELLITUS, TYPE 2; HUMANS; NEW SOUTH WALES; PHARMACIES; PROFESSIONAL ROLE; RISK ASSESSMENT; THAILAND;

EID: 84942683619     PISSN: 22121099     EISSN: 22121102     Source Type: Journal    
DOI: 10.1016/j.vhri.2015.03.022     Document Type: Article

References (27)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Australian Institute of Health and Welfare. Diabetes prevalence in Australia, Detailed estimates for 2007-2008. 2011. Available from: [Accessed June 20, 2013]. http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737419307.
3. Aekplakorn W., Chariyalertsak S., Kessomboon P., et al. Prevalence and management of diabetes and metabolic risk factors in Thai adults. Diabetes Care 2011, 34:1980-1985.
4. International Diabetes Federation. IDF diabetes atlas: the economic impacts of diabetes. 2012. Available from: [Accessed February 2, 2013]. http://www.idf.org/diabetesatlas/economic-impacts-diabetes.
5. National Public Health Partnership. Preventing chronic disease: a strategic framework. 2001. Available from: [Accessed June 9, 2013]. http://www.nphp.gov.au/publications/strategies/chrondis-bgpaper.pdf.
6. World Health Organization. The impact of chronic disease in Thailand 2002. Available from: [Accessed June 9, 2013]. http://www.who.int/chp/chronic_disease_report/thailand.pdf.
7. Alberti KGMM, Zimmet P., Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabetic Med 2007, 24:451-463.
8. Screening for type 2 diabetes. Diabetes Care 2004, 27(Suppl. 1):s11-s14. American Diabetes Association.
9. Thoopputra T., Newby D., Schneider J., Li S.C. Survey of diabetes risk assessment tools: concepts, structure and performance. Diabetes Metab Res Rev 2012, 28:485-498.
10. Chen L., Magliano D.J., Balkau B., et al. AUSDRISK: an Australian type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010, 192:197-202.
11. Aekplakorn W., Bunnag P., Woodward M., et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006, 29:1872-1877.
12. Sudchada P., Khom-ar-wut C., Eaimsongchram A., et al. Diabetes and cardiovascular risk factor controls in Thai type 2 diabetes with no history of cardiovascular complications: situation and compliance to diabetes management guideline in Thailand. J Diabetes Complicat 2012, 26:102-106.
13. Wong K.C., Brown A.M., Li S.C. AUSDRISK: application in general practice. Aust Fam Phys 2011, 40:524-526.
14. Silaruks B., Limwattananon C., Limwattananon S., Boonkaw P. Community participation in diabetes risk screening service: in the context of primary care unit. Thai J Hosp Pharm 2008, 18:52-62.
15. Blenkinsopp A., Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract 2005, 13:231-240.
16. George P.P., Molina J.A.D., Cheah J., et al. The evolving role of the community pharmacist in chronic disease management - a literature review. Ann Acad Med Singapore 2010, 39:861-867.
17. Roberts A.S., Hopp T., Sørensen E.W., et al. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci 2003, 25:227-234.
18. Scott W.G. Organization theory: an overview and an appraisal. J Acad Manag 1961, 4:7-26.
19. Benrimoj S.I., Frommer M.S. Community pharmacy in Australia. Aust Health Rev 2004, 28:238.
20. Raymond C.C., Pui Ling C. Pharmacy practice in Thailand. Am J Health-Syst Pharm 2005, 62:1408.
21. Ambady R., Chamukuttan S. Early diagnosis and prevention of diabetes in developing countries. Rev Endo Metab Disorders 2008, 9:193-201.
22. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. EuroQol Group.
23. Sreshthaputra N, Indaratna K. The Universal Coverage Policy of Thailand: An Introduction. Bangkok: Asia-Pacific Health Economics Network (APHEN), 2001. Available from: [Accessed June 20, 2013]. http://www.unescap.org/aphen/thailand_universal_coverage.htm.
24. Keawkes A., Sookaneknun P., Seesin T. Satisfaction and opinion of Mahasarakham University population toward the university pharmacies [in Thai]. J Sci Technol MSU 2010, 29:428-438.
25. Department of Health and Ageing. About the PBS. 2013. Available from: [Accessed July 19, 2013]. http://www.pbs.gov.au/info/about-the-pbs.
26. Ngorsuraches S., Li S.C. Thai pharmacists' understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm 2006, 63:2144-2150.
27. Berbatis C.G., Sunderland V.B., Joyce A., et al. Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project. Int J Pharm Pract 2007, 15:185-191.